TMLZ-G46

Overview

TMLZ-G46 is an orally active ZNF207 inhibitor with blood-brain barrier penetration ability, with a K d value of 68 nM. TMLZ-G46 inhibits cancer cell proliferation, stemness, migration and invasion, induces G0/G1 cell cycle arrest and apoptosis , and suppresses colony formation. TMLZ-G46 can be used in glioma research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Glioma | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-182358
• CAS No.: 3116767-83-7
• Molecular Formula: C37H41N3O3
• Molecular Weight: 575.74
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source